Dugan E, Blach S, Biondi M, Cai Z, DePaola M, Estes C, Feld J, Gamkrelidze I, Kottilil S, Ma S, Mathur P, Montoya S, Razavi-Shearer D, Razavi-Shearer K, Robbins-Scott S, Schmelzer J, Razavi H (2021). Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study. Lancet Gastroenterology and Hepatology 6(3):169-184.
Crossref

Echeverría N, Comas V, Aldunate F, Perbolianachis P, Moreno P, Cristina J (2021). In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? World Journal of Hepatology 13(10):1234-1268.
Crossref

Enel C, Desgrées Du Lou A, N'Dri Yoman T, Danel C, Larmarange J (2015). Les hépatites virales B et C en Côte d'Ivoire: l'urgence d'une dynamisation de la lutte. Journal Africain d'Hépato-Gastroentérologie 9:94-98.
Crossref

Kalla N, Aouidane S, Megaache F, Tebbal S (2020). Prévalence de l'infection par le virus de l'hépatite C dans la population générale de la ville de Barika Prevalence of hepatitis C virus infection in the general population of the city of Barika. Batna Journal of Medical Sciences 7:27-30.
Crossref

Kpossou AR, Kouwakanou B, Alassane KS, Bankolé MM, Ahouada C, Vignon RK, Zoundjiekpon V, Sourokou F, Séhonou J, Kodjoh N (2021). Séroprévalence des anticorps anti-virus del' hépatite C et facteurs associés, d' après un dépistage volontaire en population générale en 2016 au Bénin. Pan African Medical Journal 40(30):10.
Crossref

Masood MB, Mahbobeh O (2020). The prevalence of positive rapid diagnostic test of hepatitis C virus infection in Ghana. Pan African Medical Journal 36(1):11.

View

Meda N, Tuaillon E, Kania D, Tiendrebeogo A, Pisoni A, Zida S, Bollore K, Medah I, Laureillard D, Moles JP, Nagot N, Nebie KY, Van de Perre P, Dujols P (2018). Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study. Bulletin of the World Health Organization 96(11):750-759.
Crossref

Ongaro M, Negro F (2022). Hépatite B et C: une mise à jour sur l'hépatite virale chronique. Schweizer Gastroenterologie 3(1):19-27.
Crossref

Umutesi J, Simmons B, Makuza JD, Dushimiyimana D, Mbituyumuremyi A, Uwimana JM, Ford N, Mills EJ, Nsanzimana S (2017). Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda. BMC infectious Diseases 17(1):1-7.
Crossref

Umutesi J, Liu CY, Penkunas MJ, Makuza JD, Ntihabose CK, Umuraza S, Niyikora J, Serumondo J, Gupta N, Nsanzimana S (2019). Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population. BMJ Open 9(7):e029743.
Crossref

Zhou J, Wang FD, Li LQ, Chen EQ (2023). Management of in-and out-of-hospital screening for hepatitis C. Frontiers in Public Health 10:984810.
Crossref